Latest News

VIMKUNYA chikungunya vaccine launches for ages 12 years and olderLatest revision | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.
Vimkunya chikungunya vaccine launches for ages 12 years and older

March 18th 2025

Prior to approval on February 14, 2025, the only FDA approved vaccine for chikungunya protection was indicated for 18 years and up.

Weekly review: Roflumilast 0.05% sNDA accepted, palforzia launches for US toddlers
Weekly review: Roflumilast 0.05% sNDA accepted, palforzia launches for US toddlers

March 3rd 2025

Image Credit: © ondrooo - stock.adobe.com.
CMV linked to increased necrotizing enterocolitis severity in premature infants

March 3rd 2025

Tina Tan, MD
Tina Tan, MD, comments on the measles outbreak in Texas, vaccine-preventable diseases

February 27th 2025

Amin J. Barakat, MD, FAAP
Breaking down invasive meningococcal disease vaccines, including Penmenvy

February 20th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.